You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (2) |
Back to Search
The proportion and influential factors for patients who switch from ticagrelor to clopidogrel
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-HPS-020
- By: HUA, Yiming (China Taiwan)
- Co-author(s): Chiu-Ju Chen: Department of Pharmacy, Chi Mei Medical Center, Tainan City, Taiwan, Province of China
Yi Ming Hua: Department of Pharmacy, Chi Mei Medical Center, Tainan City, Taiwan, Province of China
Hui Chen Su: Department of Pharmacy, Chi Mei Medical Center, Tainan City, Taiwan, Province of China - Abstract:
Background
According to ESC and AHA guideline, Dual Anti-Platelet Therapy (DAPT) with Aspirin and P2Y12 receptor antagonist, such as Ticagrelor, is the gold therapy for patients with Acute Coronary Syndromes (ACS). In Taiwan, Ticagrelor is covered by Health insurance for 9 months.Purpose
The prescription rate of Ticagrelor seems less than.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026